NDC 62756-232

Loteprednol Etabonate

Loteprednol Etabonate

Loteprednol Etabonate is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Loteprednol Etabonate.

Product ID62756-232_19d17bf3-2231-4af9-b1da-ca74f015b72d
Product TypeHuman Prescription Drug
Proprietary NameLoteprednol Etabonate
Generic NameLoteprednol Etabonate
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2021-05-01
Marketing CategoryANDA /
Application NumberANDA212450
Labeler NameSun Pharmaceutical Industries, Inc.
Active Ingredient Strength5 mg/mL
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31


NDC 62756-232-55

1 BOTTLE in 1 CARTON (62756-232-55) > 10 mL in 1 BOTTLE
Marketing Start Date2021-05-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Loteprednol Etabonate" or generic name "Loteprednol Etabonate"

NDCBrand NameGeneric Name
17478-830Loteprednol EtabonateLoteprednol Etabonate
24208-508Loteprednol Etabonateloteprednol etabonate
50383-265Loteprednol EtabonateLoteprednol Etabonate
62756-232Loteprednol EtabonateLoteprednol Etabonate
68682-299Loteprednol Etabonateloteprednol etabonate
24208-353ALREXloteprednol etabonate
71571-333Eysuvisloteprednol etabonate
71571-121Inveltysloteprednol etabonate
24208-299LOTEMAXloteprednol etabonate
24208-443Lotemaxloteprednol etabonate
24208-503LOTEMAXloteprednol etabonate
24208-507Lotemax SMloteprednol etabonate

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.